Unlike GHRH analogs that stimulate the pituitary through different pathways, GHRP-2 peptide mimics the action of endogenous ghrelin to trigger a rapid, dose-dependent release of Growth Hormone (GH). Key Areas of Laboratory Investigation: GHS-R1a Binding: GHRP-2 peptide acts as a high-affinity agonist of the Growth Hormone Secretagogue Receptor. This binding initiates a signaling cascade that results in the inhibition of somatostatin (the GH-inhibiting hormone) and a direct stimulation of somatotrophs. Muscle & Tissue Recovery: Research focuses on the downstream increase of IGF-1 (Insulin-like Growth Factor 1) resulting from GH elevation. Studies observe how this axis promotes protein synthesis and the proliferation of satellite cells in skeletal muscle models. Connective Tissue & Bone Density: GHRP-2 is investigated for its positive impact on collagen synthesis and osteoblast activity. Laboratory data is used to model the reinforcement of tendons, ligaments, and the mineral matrix of bone. Appetite & Metabolic Signaling: Due to its interaction with ghrelin receptors in the hypothalamus, GHRP-2 is also a subject of research regarding hunger signaling and gastrointestinal motility, though it typically demonstrates a milder effect on appetite compared to GHRP-6. Chemical & Technical Specifications Property Specification Sequence D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2 Molecular Formula $C_{45}H_{55}N_{9}O_{6}$ Molecular Weight 817.9 g/mol Purity ≥98% (HPLC Verified) CAS Number 158861-67-7 Form Lyophilized Powder
